SYNCRIP anticorps (AA 2-191)
-
- Antigène Voir toutes SYNCRIP Anticorps
- SYNCRIP (Synaptotagmin Binding, Cytoplasmic RNA Interacting Protein (SYNCRIP))
-
Épitope
- AA 2-191
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SYNCRIP est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Heterogeneous nuclear ribonucleoprotein Q protein (2-191AA)
- Isotype
- IgG
- Top Product
- Discover our top product SYNCRIP Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- SYNCRIP (Synaptotagmin Binding, Cytoplasmic RNA Interacting Protein (SYNCRIP))
- Autre désignation
- SYNCRIP (SYNCRIP Produits)
- Synonymes
- anticorps GRY-RBP, anticorps GRYRBP, anticorps HNRNPQ, anticorps HNRPQ1, anticorps NSAP1, anticorps PP68, anticorps hnRNP-Q, anticorps 2610109K23Rik, anticorps 4632417O19Rik, anticorps Nsap1, anticorps Nsap1l, anticorps pp68, anticorps nsap1, anticorps wu:fe02c03, anticorps wu:fe47h09, anticorps SYNCRIP, anticorps hnrpq1, anticorps gry-rbp, anticorps rp1-3j17.2, anticorps synaptotagmin binding cytoplasmic RNA interacting protein, anticorps synaptotagmin binding, cytoplasmic RNA interacting protein, anticorps synaptotagmin binding cytoplasmic RNA interacting protein S homeolog, anticorps SYNCRIP, anticorps Syncrip, anticorps syncrip, anticorps syncrip.S
- Sujet
-
Background: Heterogenous nuclear ribonucleoprotein (hnRNP) implicated in mRNA processing mechanisms. Component of the CRD-mediated complex that promotes MYC mRNA stability. Isoform 1, isoform 2 and isoform 3 are associated in vitro with pre-mRNA, splicing intermediates and mature mRNA protein complexes. Isoform 1 binds to apoB mRNA AU-rich sequences. Isoform 1 is part of the APOB mRNA editosome complex and may modulate the postranscriptional C to U RNA-editing of the APOB mRNA through either by binding to A1CF (APOBEC1 complementation factor), to APOBEC1 or to RNA itself. May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. Interacts in vitro preferentially with poly(A) and poly(U) RNA sequences. Isoform 3 may be involved in cytoplasmic vesicle-based mRNA transport through interaction with synaptotagmins. Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma activation assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3\\\'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation, seems not to be essential for GAIT complex function.
Aliases: cytoplasmic RNA-interacting protein antibody, dJ3J17.2 antibody, Glycine and tyrosine rich RNA binding protein antibody, Glycine- and tyrosine-rich RNA-binding protein antibody, GRY RBP antibody, GRY-RBP antibody, GRYRBP antibody, Heterogeneous nuclear ribonucleoprotein Q antibody, hnRNP Q antibody, HNRPQ antibody, HNRPQ_HUMAN antibody, HNRPQ1 antibody, NS1 associated protein 1 antibody, NS1-associated protein 1 antibody, NSAP1 antibody, pp68 antibody, RP1 3J17.2 antibody, Synaptotagmin binding cytoplasmic RNA interacting protein antibody, Synaptotagmin-binding antibody, Syncrip antibody
- UniProt
- O60506
-